Keyphrases
Peruvian
100%
N-acetyltransferase 2 (NAT2)
48%
Cytochrome P450 2E1 (CYP2E1)
39%
Drug-induced Liver Injury
34%
Peru
32%
Genotype
30%
Anti-tuberculosis Drug-induced Hepatotoxicity
28%
Polymorphism
28%
Tuberculosis Patients
18%
Mestizo
17%
Allele Frequency
17%
Genotype Frequency
17%
Genome Project
17%
Genetic Diversity
16%
Risk Factors
16%
Anti-tuberculosis Drugs
15%
Pharmacogenetics
14%
Human Diversity
14%
Severe Influenza
14%
Arylacetamide Deacetylase
14%
GSTM1
14%
Interleukin-1 Receptor Antagonist (IL-1Ra)
14%
Magnetic Nanoparticles
14%
COVID-19
14%
GSTT1
14%
Antibiotic Resistance Genes
14%
Sewage Sample
14%
Resistome
14%
Wastewater Systems
14%
Intercellular Adhesion molecule-1 (ICAM-1)
14%
Interleukin-17 (IL-17)
14%
Community Wastewater
14%
Gelatin
14%
Biological Samples
14%
Genomic DNA Isolation
14%
Tuberculosis Biomarkers
14%
Genome Analysis
14%
Active Tuberculosis
14%
Latent Tuberculosis Infection
14%
Population Genetics
14%
Interactome
14%
Rs2070788
14%
Transmembrane Protease Serine 2 (TMPRSS2)
14%
Guillain-Barré Syndrome
14%
Epigenetics
14%
Pharmacogenetic Study
14%
Environment Health
14%
Mental Health
14%
Maternal Morbidity
14%
South America
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acyltransferase
53%
Tuberculostatic Agent
45%
CYP2E1
44%
Toxic Hepatitis
44%
Hepatotoxicity
40%
Pharmacogenetics
28%
Isoniazid
26%
Prevalence
22%
Adverse Drug Reaction
18%
Latent Tuberculosis
14%
Magnetic Nanoparticle
14%
Genomic DNA
14%
Gelatin
14%
Biological Marker
14%
Diseases
14%
SLCO1B1
9%
Cross Sectional Study
6%
Genetic Risk
6%
Cytokine
5%
Cross-Sectional Study
5%
